Encompass Health (NYSE:EHC) Rating Increased to Buy at ValuEngine

ValuEngine upgraded shares of Encompass Health (NYSE:EHC) from a hold rating to a buy rating in a research note issued to investors on Saturday, ValuEngine reports.

Other equities analysts also recently issued reports about the company. Deutsche Bank started coverage on Encompass Health in a research report on Tuesday, September 17th. They set a hold rating and a $70.00 target price on the stock. Raymond James reduced their target price on Encompass Health from $80.00 to $75.00 and set an outperform rating on the stock in a research report on Wednesday, July 31st. Bank of America upgraded Encompass Health to a buy rating in a research report on Friday, September 6th. Finally, BMO Capital Markets started coverage on Encompass Health in a research report on Thursday, June 27th. They set an outperform rating and a $72.00 target price on the stock. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Encompass Health has an average rating of Buy and an average target price of $74.60.

NYSE EHC traded up $0.37 during trading hours on Friday, hitting $66.76. 481,908 shares of the company’s stock were exchanged, compared to its average volume of 646,438. The business’s 50 day moving average is $63.10 and its 200-day moving average is $62.24. Encompass Health has a 12-month low of $56.74 and a 12-month high of $76.35. The firm has a market capitalization of $6.55 billion, a P/E ratio of 17.33, a price-to-earnings-growth ratio of 1.97 and a beta of 0.84. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.12 and a current ratio of 1.12.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, July 29th. The company reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.11. Encompass Health had a return on equity of 24.10% and a net margin of 7.01%. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.13 billion. As a group, equities research analysts anticipate that Encompass Health will post 3.81 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st were paid a dividend of $0.28 per share. The ex-dividend date was Monday, September 30th. This is a positive change from Encompass Health’s previous quarterly dividend of $0.27. This represents a $1.12 annualized dividend and a yield of 1.68%. Encompass Health’s dividend payout ratio is currently 30.85%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading: What are the benefits of a balanced fund?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.